{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:45:44Z","timestamp":1773297944299,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pbb.2019.172840","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T02:00:05Z","timestamp":1577671205000},"page":"172840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects"],"prefix":"10.1016","volume":"190","author":[{"given":"Mohammed","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Donvito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Moncayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Swafford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Olszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogna","family":"Ignatowska-Jankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2019.172840_bb0005","doi-asserted-by":"crossref","first-page":"12070","DOI":"10.1074\/jbc.M111.316463","article-title":"Allosteric modulator ORG27569 induces a CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization and Gi-independent ERK1\/2 activation","volume":"287","author":"Ahn","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2019.172840_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14203-4","article-title":"Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors","volume":"7","author":"Bhattacharyya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2019.172840_bb6500","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bph.12329","article-title":"Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action","volume":"170","author":"Cawston","year":"2013","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.pbb.2019.172840_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(91)90739-G","article-title":"Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study","volume":"129","author":"Chen","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"9600","key":"10.1016\/j.pbb.2019.172840_bb0025","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"issue":"6604","key":"10.1016\/j.pbb.2019.172840_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.pbb.2019.172840_bb0035","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2019.172840_bb0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.172840_bb0045","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pbb.2019.172840_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.69","article-title":"Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats","volume":"2","author":"Ding","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"issue":"16","key":"10.1016\/j.pbb.2019.172840_bb0055","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pbb.2019.172840_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6663(88)80017-5","article-title":"Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory","volume":"11","author":"Foltin","year":"1988","journal-title":"Appetite"},{"issue":"11","key":"10.1016\/j.pbb.2019.172840_bb0065","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1017\/S0033291717003361","article-title":"Psychosocial functioning among regular cannabis users with and without cannabis use disorder","volume":"48","author":"Foster","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2019.172840_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FBP.0000000000000027","article-title":"In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator ORG27569","volume":"25","author":"Gamage","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2019.172840_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2017.08.008","article-title":"The great divide: separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators","volume":"125","author":"Gamage","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.172840_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","article-title":"Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2019.172840_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-199201000-00018","article-title":"Dronabinol effects on weight in patients with HIV infection","volume":"6","author":"Gorter","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.pbb.2019.172840_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.pbb.2019.172840_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","article-title":"PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats","volume":"152","author":"Horswill","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.pbb.2019.172840_bb0100","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.172840_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2014.08.004","article-title":"Effects of the cannabinoid CB\u2081 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats","volume":"143","author":"Jing","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2019.172840_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.pbb.2019.172840_bb0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tips.2018.05.001","article-title":"PAM-antagonists: a better way to block pathological receptor signaling?","volume":"39","author":"Kenakin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.pbb.2019.172840_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/carcin\/18.1.107","article-title":"Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone","volume":"18","author":"Kessler","year":"1997","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.pbb.2019.172840_bb0125","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1021\/jm5000112","article-title":"Optimization of chemical functionalities of indole-2-carboxamides to improve allosteric parameters for the cannabinoid receptor 1 (CB1)","volume":"57","author":"Khurana","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2019.172840_bb0130","doi-asserted-by":"crossref","first-page":"PL365","DOI":"10.1016\/0024-3205(96)00237-8","article-title":"Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains","volume":"58","author":"Lepore","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2019.172840_bb0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02246292","article-title":"Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats","volume":"119","author":"Lichtman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.172840_bb0835","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.pbb.2019.172840_bb0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2019.172840_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2019.172840_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side-effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.pbb.2019.172840_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"Pt A","key":"10.1016\/j.pbb.2019.172840_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2019.172840_bb0165","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1208\/aapsj070364","article-title":"The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids","volume":"7","author":"Pertwee","year":"2005","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.pbb.2019.172840_bb0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jat\/34.8.516","article-title":"Disposition of cannabichromene, cannabidiol, and \u03949-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry","volume":"34","author":"Poklis","year":"2010","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.pbb.2019.172840_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jat\/bkv079","article-title":"Identification of metabolite biomarkers of the designer hallucinogen 25I-NBOMe in mouse hepatic microsomal preparations and human urine samples associated with clinical intoxication","volume":"39","author":"Poklis","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"20","key":"10.1016\/j.pbb.2019.172840_bb0180","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1001\/jama.1981.03310450039020","article-title":"Delta 9-tetrahydrocannabinol in clinical oncology","volume":"245","author":"Poster","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2019.172840_bb0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor","volume":"68","author":"Price","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2019.172840_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0269881108092393","article-title":"Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users","volume":"23","author":"Ramaekers","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.172840_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fpsyt.2018.00281","article-title":"Effects of adolescent THC exposure on the prefrontal GABAergic system: implications for schizophrenia-related psychopathology","volume":"9","author":"Renard","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pbb.2019.172840_bb0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tips.2007.10.006","article-title":"Allosterism and cannabinoid CB(1) receptors: the shape of things to come","volume":"28","author":"Ross","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2019.172840_bb0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.pbb.2019.172840_bb0210","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.172840_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.pbb.2019.172840_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2019.172840_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in pre-fed rats following oral delta9-THC","volume":"65","author":"Williams","year":"1998","journal-title":"Physiol. Behav."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719302709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719302709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:36:57Z","timestamp":1758775017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305719302709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":46,"alternative-id":["S0091305719302709"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172840","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172840"}}